top of page
Recent Posts

Dexrazoxane Can Mediate Cardiotoxicity in Childhood Cancer Survivors

Survivors of childhood cancers are at significantly increased risk of cardiotoxicity if treated with anthracyclines, according to a new review of the literature. That toxicity, though, can be substantially ameliorated if dexrazoxane is administered before each anthracycline dose.

Read more here:

Search By Tags
bottom of page